Metraipolis › archive › dc_21d442db51fa

Individualised dosimetry for holmium-166 RE in patients with unresectable hepatocellular carcinoma; a multi-centre, interventional, non-randomised,… — Europe PMC PMID:41263849

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41263849
DOI
10.1136/bmjopen-2024-097066
License (as archived)
solo-consultazione
Archived
2026-11-08T10:19:31.254Z
SHA-256 of the archived text
a745c53c34ff2820f6d474169f13fbfc7cf3dc1e01af3b3e3546723c94bcc853
Stable URL of this page
https://metraipolis.com/documento/dc_21d442db51fa

How to cite

Individualised dosimetry for holmium-166 RE in patients with unresectable hepatocellular carcinoma; a multi-centre, interventional, non-randomised,… — Europe PMC PMID:41263849 — Europe PMC (en), https://europepmc.org/article/MED/41263849 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_21d442db51fa (Metraipolis archive dc_21d442db51fa, sha256 a745c53c34ff2820f6d474169f13fbfc7cf3dc1e01af3b3e3546723c94bcc853)
BibTeX
@misc{dc21d442db51fa,
  title = {Individualised dosimetry for holmium-166 RE in patients with unresectable hepatocellular carcinoma; a multi-centre, interventional, non-randomised,… — Europe PMC PMID:41263849},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41263849},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_21d442db51fa; sha256 a745c53c34ff2820f6d474169f13fbfc7cf3dc1e01af3b3e3546723c94bcc853},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41263849. Agents can read the archived copy with the MCP tool read_document.